Abdelaziz Fahem: HLH in the GCC – A New Regional Consensus for Diagnosis and Management
Abdelaziz Fahem, Vice President of Medical Affairs and Clinical Research at Hemara Bio, shared a post on LinkedIn about a recent article by Mohamed A. Yasin, published in Frontiers in Immunology, adding:
“HLH in the GCC finally has a consensus.
Our paper, ‘Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis in the Gulf Cooperation Council: a modified Delphi approach,’ has just been published in Frontiers in Immunology.
This is a significant publication for the HLH community in the Gulf.
HLH is a rare and life-threatening hyperinflammatory syndrome where delayed recognition or inappropriate management can have serious consequences. Until now, there has been a need for region-specific recommendations reflecting the clinical realities and expertise of the GCC.
This consensus brings together 15 experts from all six GCC countries, using a structured modified Delphi process to develop recommendations covering key aspects of HLH diagnosis and management.
Publishing this work in Frontiers in Immunology, a well-established international immunology journal with an Impact Factor of 7.0, gives these GCC recommendations a much broader scientific platform and visibility.
A special thank you to Dr Hind Salama and Pr Mohamed Yassin, who led this important initiative, and to all the experts who contributed their time, experience and scientific input.
I am particularly pleased to have contributed to a project that combines international scientific standards with regional clinical expertise, addressing an important unmet need in rare disease care.”
Title: Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis in the Gulf Cooperation Council: a modified Delphi approach
Authors: Mohamed A. Yasin, Muna Al Rasheed, Murtadha Al Khabori, Yasser Wali, Abdelaziz Fahem, Afaf Al Battah, Cigdem Pala Ozturk, Hani Yousif Osman, Maha Sabkar, Mahmoud Marashi, Mozah Al Marshoodi, Nisreen Khalifa, Shehab Mohamed, Salam Al Kindi, Tarek E. Abouzeid, Hind Salama
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 4, 2026, 18:57Connecting Haemophilia Centres, Certifying Treaters, and Improving National Data in Romania – EHC
-
Nov 4, 2026, 18:45Smitirupa Mishra: A Practical Guide to Coagulation Pathway Assessment and Laboratory Interpretation
-
Nov 4, 2026, 15:59Alessandra Bosch: A Successful Patient Day for the Bleeding Disorders Community in Zürich
-
Nov 4, 2026, 15:47Wolfgang Miesbach: Targeting Hepatic Endothelial Cells for Lentiviral Gene Therapy in Haemophilia A
-
Nov 4, 2026, 15:20Augustina Isioma Ikusemoro: Before You Transfuse, Think PBM
-
Nov 4, 2026, 14:23Advancing Hemophilia Care Through Global Research – WFH
-
Nov 4, 2026, 14:12Jean-Jacques Kiladjian: From JAK Inhibitor-Associated Skin Cancers to Laboratory Discovery
-
Nov 4, 2026, 13:59Rita Li: ASH 2026 Abstract Achievement Award for Gut Microbiome Research
-
Nov 4, 2026, 13:38Omid Seidizadeh: Improving Access to von Willebrand Disease Diagnosis and Treatment Across Europe